Skip to main content
TipRanks
Go Ultimate75% OFF

Compare Vitasora Health (VHLUF) vs. Competitors

5 Followers

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
VHLUFVitasora Health$0.00$19.08M-2.07-3.33%―Unlock the VHLUF analyst price target with TipRanks PremiumVHLUFUnlock the VHLUF top-analyst price target with TipRanks Premium
AU:ONEOneview Healthcare Chess Depository Interests repr 1AUD 0.14AUD 117.49M-6.72-47.17%Moderate BuyUnlock the AU:ONE analyst price target with TipRanks PremiumVHLUF vs AU:ONEUnlock the AU:ONE top-analyst price target with TipRanks Premium
AU:M7TMach7 TechnologiesAUD 0.27AUD 63.45M-7.11-16.92%Moderate BuyUnlock the AU:M7T analyst price target with TipRanks PremiumVHLUF vs AU:M7TUnlock the AU:M7T top-analyst price target with TipRanks Premium
AU:BMTBeamtree Holdings LtdAUD 0.07AUD 20.08M-1.08-66.00%Moderate BuyUnlock the AU:BMT analyst price target with TipRanks PremiumVHLUF vs AU:BMTUnlock the AU:BMT top-analyst price target with TipRanks Premium
AU:ALCAlcidion Group LimitedAUD 0.12AUD 155.23M67.659.52%Strong BuyUnlock the AU:ALC analyst price target with TipRanks PremiumVHLUF vs AU:ALCUnlock the AU:ALC top-analyst price target with TipRanks Premium
AU:PCKPainChek LtdAUD 0.07AUD 14.44M-1.59-84.67%―Unlock the AU:PCK analyst price target with TipRanks PremiumVHLUF vs AU:PCKUnlock the AU:PCK top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%150%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
VHLUFVitasora Health0.060.000.00%
AU:ONEOneview Healthcare Chess Depository Interests repr 10.14-0.13-48.15%
AU:M7TMach7 Technologies0.27-0.05-15.63%
AU:BMTBeamtree Holdings Ltd0.07-0.13-66.00%
AU:ALCAlcidion Group Limited0.120.014.55%
AU:PCKPainChek Ltd0.07-0.35-83.57%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts